SCHEMBL5599019

SCHEMBL5599019

COc1cc2nccc(Oc3ccc(CC(=O)Nc4noc(C)c4C)cc3)c2cn1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 11/20 0.64
CSF1R P07333 9/20 0.64
KDR P35968 6/20 0.64
FLT3 P36888 4/20 0.64
FLT4 P35916 1/20 0.49
MET P08581 6/20 0.49
ENPP1 P22413 1/20 0.47
PDGFRA P16234 3/20 0.45
KIT P10721 2/20 0.45
RET P07949 1/20 0.44
DDR1 Q08345 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MAPK10 P53779 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5598693 0.89 PDGFRB (0.81) PDGFRBCSF1RKDRFLT3MET
SCHEMBL2176626 0.89 PDGFRB (0.81) PDGFRBCSF1RKDRFLT3FLT4
SCHEMBL5598876 0.86 PDGFRB (0.60) PDGFRBCSF1RKDRFLT3FLT4
SCHEMBL2174541 0.84 PDGFRB (0.69) PDGFRBCSF1RKDRFLT3FLT4
SCHEMBL5598622 0.84 PDGFRB (0.60) PDGFRBCSF1RKDRFLT3FLT4
SCHEMBL5598979 0.81 CSF1R (0.64) PDGFRBCSF1RKDRFLT3FLT4
SCHEMBL5610715 0.79 SMN1; SMN2 (0.55) PDGFRBCSF1RKDRFLT3FLT4
SCHEMBL4514639 0.79 PDGFRB (0.77) PDGFRBCSF1RKDRFLT3FLT4
SCHEMBL4209677 0.79 PDGFRB (0.77) PDGFRBCSF1RKDRFLT3FLT4
SCHEMBL4498740 0.78 PDGFRB (0.79) PDGFRBCSF1RKDRFLT3MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007113565-A1 NAPHTHYRIDINE DERIVATIVES AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2007-10-11 WO disclosed